Fora Capital, LLC Halozyme Therapeutics, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$40.06 - $59.44 $66,259 - $98,313	1,654 Added 15.04%	12,648 $719,000
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $423,598 - $569,269	10,994 New	10,994 $435,000
Q2 2022 Aug 11, 2022	SELL	$37.35 - $48.3 $239,114 - $309,216	-6,402 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$31.97 - $41.06 $204,671 - $262,866	6,402 New	6,402 $257,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $249,074 - $391,171	-17,919 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $267,530 - $349,958	17,919 New	17,919 $317,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.